Paraoxonase 3 promotes cell proliferation and metastasis by PI3K/Akt in oral squamous cell carcinoma

被引：18
作者：
Zhu, Lili [1 ]
Shen, Yiyin [1 ]
Sun, Wei [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Stomatol, Shanghai, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2017年 / 85卷
关键词：
PON3; OSCC; Cell proliferation; AP-1; IMMUNE ESCAPE; CANCER; PATHWAY;
D O I：
10.1016/j.biopha.2016.11.084
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Paraoxonase 3 (PON3) is an oncogene in cancer, however, little is known about the mechanisms and roles of PON3 in oral squamous cell carcinoma (OSCC), which is the aim of our study. We found that the expression of PON3 was up-regulated in OSCC samples and cell lines. PON3 was associated with accelerating cell proliferation, cell cycle, migration and invasion in OSCC cells. Further research showed that PON3 was regulated by PI3K/Akt pathway. We also found that AP-1 was an important transcriptional factor regulating PON3 expression in OSCC. The study elucidates that PI3K/Akt pathway up-regulated the expression of PON3 in OSCC by AP-1. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：712 / 717
页数：6
相关论文
共 50 条
[21]   HOXC10 promotes nasopharyngeal carcinoma cell proliferation and migration by regulating PI3K/AKT pathway [J].
Wu, Liping ;
Qian, Guohong ;
Zheng, Yuqing ;
Zheng, Huizhen .
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (08) :1595-1600
[22]   TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the AKT signaling pathway [J].
Shen, Peng ;
Zhang, Tian-Yang ;
Wang, Shu-Yan .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (04)
[23]   NEAT1 promotes cell proliferation in multiple myeloma by activating PI3K/AKT pathway [J].
Xu, H. ;
Li, J. ;
Zhou, Z. -G. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (19) :6403-6411
[24]   Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway [J].
Ge, Shengyou ;
Wang, Kexin ;
Meng, Yuxiang ;
He, Zongxuan ;
Yang, Xiaochen ;
Shang, Wei ;
Wang, Lin .
MEDICAL ONCOLOGY, 2023, 40 (10)
[25]   Knockdown of Metadherin suppressed the progression of oral squamous cell carcinoma via PI3K/AKT signaling pathway [J].
Ding, Z. Y. ;
Dong, G. ;
Yin, G. ;
Yu, L. L. ;
Li, W. X. ;
Ding, B. .
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (01) :303-309
[26]   Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck [J].
Simpson, Daniel R. ;
Mell, Loren K. ;
Cohen, Ezra E. W. .
ORAL ONCOLOGY, 2015, 51 (04) :291-298
[27]   NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling [J].
Gong, Chengwu ;
Ai, Jiyuan ;
Fan, Yun ;
Gao, Jun ;
Liu, Weiwei ;
Feng, Qian ;
Liao, Wenjun ;
Wu, Linquan .
ONCOTARGETS AND THERAPY, 2019, 12 :8537-8552
[28]   SCARA5 inhibits oral squamous cell carcinoma via inactivating the STAT3 and PI3K/AKT signaling pathways [J].
Huang, Juan ;
Lv, Chunhua ;
Zhao, Baoyu ;
Ji, Zhongqian ;
Gao, Zhenran .
OPEN MEDICINE, 2023, 18 (01)
[29]   Tra2β silencing suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting PI3K/AKT signaling [J].
Ni, Hao-Sheng ;
Hu, Song-Qun ;
Chen, Xi ;
Liu, Yi-Fei ;
Ni, Ting-Ting ;
Cheng, Lei .
LARYNGOSCOPE, 2019, 129 (09) :E318-E328
[30]   Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway [J].
Qu, Yi ;
He, Ying ;
Ruan, Hanjin ;
Qin, Lizheng ;
Han, Zhengxue .
CANCER MEDICINE, 2023, 12 (05) :5781-5797
12345